Literature DB >> 22193223

Infection-associated haemophagocytic lymphohistiocytosis: a case series using steroids only protocol for management.

Prabhas Prasun Giri1, Priyankar Pal, Apurba Ghosh, Rajiv Sinha.   

Abstract

Haemophagocytic lymphohistiocytosis (HLH) is a heterogeneous group of clinical syndromes characterised by activation and subsequent uncontrolled non-malignant proliferation of T lymphocytes and macrophages, leading to a cytokine storm that accounts for most of its clinical features such as acute febrile illness, hepatosplenomegaly, multi-organ dysfunction and fulminant pancytopenia-resembling severe sepsis. Here, we present a series of 23 cases of infection-associated HLH diagnosed in our hospital within a time period of last three and half years. Though the presentation and progression of disease was variable, the patients shared some common features like prolonged fever unresponsive to broad spectrum antibiotics, organomegaly and cytopenias. In most of the cases, however, the triggering infectious agent could not be identified. They were treated using a steroid only protocol along with supportive measures and showed an excellent response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22193223     DOI: 10.1007/s00296-011-2291-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  8 in total

Review 1.  Modern management of children with haemophagocytic lymphohistiocytosis.

Authors:  Gritta E Janka; E M Schneider
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

2.  Hemophagocytic syndrome.

Authors:  V J Joseph; A O Sunny; N Pandit; M Yeshwanth
Journal:  Indian Pediatr       Date:  1992-07       Impact factor: 1.411

3.  Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India.

Authors:  B Ramachandran; S Balasubramanian; N Abhishek; K G Ravikumar; A V Ramanan
Journal:  Indian Pediatr       Date:  2010-08-01       Impact factor: 1.411

Review 4.  Familial erythrophagocytic lymphohistiocytosis.

Authors:  T S Loy; A A Diaz-Arias; M C Perry
Journal:  Semin Oncol       Date:  1991-02       Impact factor: 4.929

Review 5.  Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis.

Authors:  G Janka; S Imashuku; G Elinder; M Schneider; J I Henter
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

6.  Familial hemophagocytic lymphohistiocytosis and viral infections.

Authors:  J I Henter; A Ehrnst; J Andersson; G Elinder
Journal:  Acta Paediatr       Date:  1993-04       Impact factor: 2.299

7.  Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases.

Authors:  N Esumi; S Ikushima; S Todo; S Imashuku
Journal:  Acta Paediatr Scand       Date:  1989-03

8.  Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society.

Authors:  M Aricò; G Janka; A Fischer; J I Henter; S Blanche; G Elinder; M Martinetti; M P Rusca
Journal:  Leukemia       Date:  1996-02       Impact factor: 11.528

  8 in total
  3 in total

1.  Hyperferritinemia in Hemophagocytic Lymphohistiocytosis: A Single Institution Experience in Pediatric Patients.

Authors:  Surupa Basu; Biplab Maji; Santanu Barman; Apurba Ghosh
Journal:  Indian J Clin Biochem       Date:  2017-05-05

2.  Haemophagocytic lymphohistiocytosis presenting as liver failure following Epstein-Barr and prior hepatitis A infections.

Authors:  Gineth Paola Pinto-Patarroyo; Michael E Rytting; John Moore Vierling; Maria E Suarez-Almazor
Journal:  BMJ Case Rep       Date:  2013-08-13

3.  Hemophagocytic Lymphohistiocytosis as Initial Presentation of Malignancy in Pediatric Patients: Rare but Not to Be Ignored.

Authors:  Hye-Ji Han; Kyung Taek Hong; Hyun Jin Park; Bo Kyung Kim; Hong Yul An; Jung Yoon Choi; Hyoung Jin Kang
Journal:  Children (Basel)       Date:  2021-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.